Visceral Fat & Cardiometabolic Optimization Advanced Panel
Gain advanced insight into metabolic, cardiovascular, and hormonal health with the Visceral Fat and Cardiometabolic Optimization Advanced Panel. This panel evaluates glucose, insulin, lipids, inflammation, liver enzymes, advanced lipoproteins, thyroid markers, and sex hormones to provide a comprehensive view of visceral fat related cardiometabolic function.
- $1,738.59
- $349
- Save: 79.93%
The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Apolipoprotein B
Also known as: Chem 12, Chemistry Panel, Chemistry Screen, CMP, Complete Metabolic Panel, Comprehensive Metabolic Panel CMP, SMA 12, SMA 20
Albumin
Albumin/Globulin Ratio
Alkaline Phosphatase
Alt
AST
Bilirubin, Total
Bun/Creatinine Ratio
Calcium
Carbon Dioxide
Chloride
Creatinine
Egfr African American
Egfr Non-Afr. American
GFR-AFRICAN AMERICAN
GFR-NON AFRICAN AMERICAN
Globulin
Glucose
Potassium
Protein, Total
Sodium
Urea Nitrogen (Bun)
Also known as: Cortisol AM
Cortisol, A.M.
Estradiol
Ferritin
Also known as: Gamma Glutamyl Transferase GGT, Gamma-Glutamyl Transferase, Gamma-Glutamyl Transpeptidase, Gamma-GT, GGTP, GTP
Ggt
Also known as: A1c, Glycated Hemoglobin, Glycohemoglobin, Glycosylated Hemoglobin, HA1c, HbA1c, Hemoglobin A1c, Hemoglobin A1c HgbA1C, Hgb A1c
HEMOGLOBIN A1C
Also known as: C-Reactive Protein, Cardio CRP, Cardio hs-CRP, CRP, High Sensitivity CRP, High-sensitivity C-reactive Protein, High-sensitivity CRP, Highly Sensitive CRP, hsCRP, Ultra-sensitive CRP
Hs Crp
Also known as: Insulin (fasting)
Insulin
Also known as: Lipid Panel with Ratios (fasting), Lipid Profile with Ratios (fasting), Lipids
Chol/HDLC Ratio
Cholesterol, Total
HDL Cholesterol
LDL-Cholesterol
LDL/HDL Ratio
Non HDL Cholesterol
Triglycerides
HDL P
HDL SIZE
LARGE HDL P
LARGE VLDL P
LDL P
LDL SIZE
SMALL LDL P
VLDL SIZE
Also known as: Free T3, FT3, T3 Free
T3, Free
Also known as: Free T4, FT4, T4 Free
T4, Free
Also known as: Testosterone Total And Free And Sex Hormone Binding Globulin
Free Testosterone
Sex Hormone Binding
TESTOSTERONE, TOTAL,
Also known as: Thyroid Stimulating Hormone Test, Thyrotropin Test
TSH
The Visceral Fat & Cardiometabolic Optimization Advanced Panel panel contains 15 tests with 50 biomarkers .
Advanced Insight into Metabolic, Cardiovascular, and Hormonal Health
The Visceral Fat and Cardiometabolic Optimization Advanced Panel is a comprehensive blood test designed to evaluate key biomarkers associated with visceral fat, metabolic function, cardiovascular risk, and endocrine balance. This panel integrates foundational metabolic testing with advanced lipid analysis, inflammatory markers, iron status, and a full spectrum of hormonal markers including thyroid regulation. By assessing multiple interconnected systems, it provides a detailed and clinically relevant overview of cardiometabolic health.
Visceral fat is metabolically active and influences glucose regulation, lipid metabolism, inflammation, liver function, and hormone signaling. This panel evaluates these pathways simultaneously, allowing for a more complete understanding of how metabolic and hormonal systems interact. In addition to standard metabolic and lipid markers, it includes advanced cardiovascular indicators such as apolipoprotein B and lipoprotein fractionation by nuclear magnetic resonance, which provide deeper insight into lipoprotein particle number and size.
Hormonal markers such as cortisol, testosterone, estradiol, and sex hormone binding globulin offer additional context related to endocrine function and metabolic regulation. Thyroid markers including thyroid stimulating hormone, free T3, and free T4 help assess how the thyroid is regulated and how effectively thyroid hormones are produced and utilized. Ferritin is included to evaluate iron stores, which can influence metabolic processes and overall physiological function.
By combining these diverse biomarkers, the panel provides a multidimensional view of how metabolic, cardiovascular, and hormonal systems are functioning together. It is designed for both baseline evaluation and ongoing monitoring, offering structured insight into complex cardiometabolic interactions.
When and Why Someone Would Order This Panel
Situations That May Prompt Advanced Cardiometabolic Evaluation
The Visceral Fat and Cardiometabolic Optimization Advanced Panel may be considered when a comprehensive and detailed evaluation of metabolic health is needed, particularly in relation to visceral fat and its systemic effects. Because visceral fat is associated with changes in glucose metabolism, lipid balance, inflammation, and endocrine signaling, evaluating these pathways together can provide a more complete understanding of overall health.
This panel may be ordered in situations where there is interest in assessing cardiometabolic risk factors beyond standard testing. While traditional lipid panels offer valuable information, advanced markers such as apolipoprotein B and lipoprotein particle analysis can provide additional insight into lipid related risk patterns. These markers help characterize lipoprotein concentration and distribution, offering a more detailed view of cardiovascular health.
It may also be useful for evaluating insulin sensitivity and long term glucose regulation. Hemoglobin A1c reflects average blood glucose levels over time, while fasting insulin provides insight into how the body is responding to glucose. Together, these markers help identify patterns that may be associated with insulin resistance or metabolic imbalance.
Hormonal assessment is another key reason for ordering this panel. Testosterone, estradiol, and sex hormone binding globulin provide insight into sex hormone balance, while cortisol reflects adrenal activity and stress response. Thyroid markers including thyroid stimulating hormone, free T3, and free T4 are essential for evaluating metabolic rate and energy regulation.
This panel may also be used for monitoring changes related to lifestyle modifications such as nutrition, physical activity, or weight management strategies. By tracking a wide range of biomarkers over time, individuals and healthcare providers can observe how metabolic and hormonal systems respond. It may also support evaluation of patterns associated with metabolic syndrome, cardiovascular risk, thyroid dysfunction, or metabolic related liver changes.
What Does the Panel Measure
Comprehensive Biomarker Categories and Their Roles
Metabolic and Organ Function Markers
The Comprehensive Metabolic Panel includes glucose, kidney markers such as blood urea nitrogen and creatinine, liver enzymes including alanine aminotransferase and aspartate aminotransferase, electrolytes, and protein levels. These markers provide a broad overview of metabolic processes, organ function, and fluid balance. Glucose, included within this panel, reflects current blood sugar levels.
Lipid and Advanced Cardiovascular Markers
The Lipid Panel measures total cholesterol, low density lipoprotein cholesterol, high density lipoprotein cholesterol, and triglycerides. Apolipoprotein B reflects the number of atherogenic lipoprotein particles, offering additional insight into cardiovascular risk. Lipoprotein fractionation by nuclear magnetic resonance evaluates lipoprotein particle size and concentration, providing a detailed assessment of lipid metabolism and particle distribution.
Glucose Regulation and Insulin
Hemoglobin A1c measures average blood glucose levels over approximately two to three months. Fasting insulin evaluates how the body responds to glucose and provides insight into insulin sensitivity. These markers help assess how effectively blood sugar is being regulated over time.
Inflammation and Liver Function
High sensitivity C reactive protein is a marker of low grade systemic inflammation and can provide insight into inflammatory processes associated with cardiometabolic health. Gamma glutamyl transferase is an enzyme linked to liver function and oxidative stress, offering additional context for liver related metabolic activity.
Iron Status
Ferritin reflects stored iron levels in the body and provides insight into iron balance. Iron status can influence oxygen transport, energy production, and metabolic function.
Hormonal and Endocrine Markers
Cortisol, measured in the morning, reflects adrenal activity and daily stress response patterns. Testosterone, both free and total, along with estradiol and sex hormone binding globulin, provide insight into sex hormone production, conversion, and availability. Thyroid stimulating hormone evaluates pituitary signaling to the thyroid, while free T4 reflects hormone production and free T3 represents the active hormone influencing metabolism at the cellular level.
By combining these biomarker categories, the panel offers a comprehensive map of metabolic, cardiovascular, and endocrine pathways.
How Patients and Healthcare Providers Use the Results
Interpreting Integrated Cardiometabolic Patterns
Results from the Visceral Fat and Cardiometabolic Optimization Advanced Panel are typically interpreted by examining relationships across multiple systems. Glucose, insulin, and Hemoglobin A1c are evaluated together to assess glycemic control and insulin sensitivity. Lipid markers, including apolipoprotein B and lipoprotein particle analysis, provide insight into lipid transport and cardiovascular risk patterns.
Inflammatory markers such as high sensitivity C reactive protein are considered alongside lipid and metabolic markers to evaluate overall cardiometabolic balance. Liver enzymes and gamma glutamyl transferase help provide context for how the liver is processing metabolic demands. Ferritin adds information about iron status, which can influence metabolic and physiological function.
Hormonal markers are interpreted within the context of endocrine regulation. Testosterone, estradiol, and sex hormone binding globulin help evaluate hormone balance and availability, while cortisol reflects adrenal function. Thyroid stimulating hormone, free T4, and free T3 are assessed together to understand thyroid regulation and metabolic activity.
Supporting Monitoring and Longitudinal Assessment
This panel can be used to monitor changes over time, particularly in response to lifestyle modifications or clinician guided interventions. Tracking trends across metabolic, lipid, inflammatory, and hormonal markers provides a dynamic view of health. It allows for evaluation of whether metabolic pathways are improving, remaining stable, or showing patterns that may require further assessment.
Clinical Context and Broader Health Insights
The results may contribute to the evaluation of conditions such as insulin resistance, metabolic syndrome, dyslipidemia, and cardiometabolic risk patterns. Advanced lipid markers may provide additional insight into atherosclerotic risk, while inflammatory markers can help evaluate systemic inflammation. Thyroid markers may help identify patterns consistent with hypothyroidism or hyperthyroidism, and hormonal markers may support evaluation of endocrine balance. Liver enzymes and ferritin may provide insight into metabolic related liver changes and iron status.
It is important that results are interpreted within the context of clinical history, lifestyle factors, and timing of testing. This panel provides a comprehensive dataset that can support further evaluation and guide a more complete understanding of cardiometabolic health.
A Multidimensional Approach to Cardiometabolic Optimization
The Visceral Fat and Cardiometabolic Optimization Advanced Panel offers a comprehensive and integrated approach to evaluating the complex relationships between metabolic, cardiovascular, and hormonal systems. By combining foundational and advanced biomarkers, it provides a detailed view of how the body regulates energy, processes lipids, and maintains endocrine balance.
Visceral fat is closely linked to metabolic activity, and its effects are reflected across multiple biological pathways. This panel captures those interactions by evaluating glucose regulation, lipid metabolism, inflammation, liver function, iron status, and hormone signaling, including full thyroid assessment. The inclusion of advanced lipid markers and endocrine hormones allows for a more nuanced and comprehensive understanding of cardiometabolic health.
Designed for both baseline assessment and ongoing monitoring, the panel supports a deeper exploration of metabolic trends and physiological changes over time. It provides clinically relevant information that can help guide further evaluation and support informed decision making.
By emphasizing clarity, integration, and clinical relevance, the Visceral Fat and Cardiometabolic Optimization Advanced Panel reinforces the value of a comprehensive perspective when evaluating cardiometabolic health. It serves as a valuable tool for understanding how interconnected systems function together and supports a more personalized approach to health monitoring.